Formulations for IL-11
US6270757A · kind A · utility
28Cited by
10References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 21, 1994 |
| Grant date | Aug 7, 2001 |
| Priority date | — |
| Expiry date | Apr 21, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel formulations comprising IL-11 and glycine. Also provided are compositions, both liquid and lyophilized, comprising IL-11 and glycine and optionally, a buffering agent such as histidine and phosphate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.